The core activity of C2 Health Consulting is the creation of Health Economic (HEOR) and Market Access services for the pharmaceutical industry. This includes: development of health-economic models, such as cost-benefit analyses and budget impact analyses; conducting indirect treatment comparisons (ITCs) and survival analyses; creation of Global Value Dossiers (GVDs) and value communication documents; and support with price and reimbursement negotiations (P&R) with decision-makers and payers. The company supports its clients in communicating the value of new pharmaceutical products and creating tools that enable a positive reimbursement recommendation in target markets.